Urological research, Malmö
1 – 183 of 183
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A non-invasive 25-Gene PLNM-Score urine test for detection of prostate cancer pelvic lymph node metastasis
2024) In Prostate Cancer and Prostatic Diseases(
- Contribution to journal › Article
- 2021
-
Mark
Androgen deprivation therapy and side effects : Are GnRH antagonists safer?
(
- Contribution to journal › Scientific review
-
Mark
Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms
(
- Contribution to journal › Article
- 2020
-
Mark
Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up
(
- Contribution to journal › Article
-
Mark
Considerations for the use of gonadotropin-releasing hormone agonists and antagonists in patients with prostate cancer
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer : The European Association of Urology Position in 2019
(
- Contribution to journal › Article
-
Mark
The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia : An in vitro study
(
- Contribution to journal › Article
- 2017
-
Mark
Effect of microsurgical subinguinal varicocele repair on chronic dull scrotal pain in men with grade II-III lesions
(
- Contribution to journal › Article
-
Mark
In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)
(
- Contribution to journal › Article
-
Mark
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder : Association with tumor stage, lymph node metastases, FDG-PET findings, and survival
(
- Contribution to journal › Article
-
Mark
Intermittent androgen deprivation therapy in patients with prostate cancer : Connecting the dots
(
- Contribution to journal › Article
-
Mark
Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy
(
- Contribution to journal › Article
- 2016
-
Mark
Vitamin D, PTH, and calcium and tumor aggressiveness in prostate cancer: a prospective nested case-control study.
(
- Contribution to journal › Article
-
Mark
Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment.
(
- Contribution to journal › Article
-
Mark
Clear Cell Adenocarcinoma of the Female Urethra: Four Case Presentations of a Clinical and Pathological Entity Requiring Radical Surgery.
2016) In Urologia Internationalis(
- Contribution to journal › Article
-
Mark
Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis
(
- Contribution to journal › Article
-
Mark
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells
(
- Contribution to journal › Article
-
Mark
Association between PSA Levels and Biomarkers of Subclinical Systemic Inflammation in Middle-Aged Healthy Men from the General Population
(
- Contribution to journal › Article
-
Mark
Association between Erectile Function and Biomarkers of Subclinical Atherosclerosis : A Study Based on Middle-Aged Healthy Men from the General Population
(
- Contribution to journal › Article
- 2015
-
Mark
Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma.
(
- Contribution to journal › Article
-
Mark
Contemporary approaches for imaging skeletal metastasis.
(
- Contribution to journal › Scientific review
-
Mark
Biological determinants of bladder cancer gene expression subtypes.
(
- Contribution to journal › Article
-
Mark
Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.
(
- Contribution to journal › Scientific review
-
Mark
Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study.
(
- Contribution to journal › Article
-
Mark
Simplified intraoperative sentinel-node detection performed by the urologist accurately determines lymph-node stage in prostate cancer.
(
- Contribution to journal › Article
-
Mark
A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
(
- Contribution to journal › Article
-
Mark
Surgical interventions for nephrolithiasis in ankylosing spondylitis and the general population.
(
- Contribution to journal › Article
-
Mark
A major population of mucosal memory CD4(+) T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality.
(
- Contribution to journal › Article
-
Mark
Use of bacillus Calmette-Guérin in stage T1 bladder cancer: Long-term observation of a population-based cohort.
(
- Contribution to journal › Article
-
Mark
Targeting the Mechanisms of Progression in Castration-resistant Prostate Cancer.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reply from Authors re: Bas W.G. van Rhijn, Mark A. Behrendt, Kees Hendricksen, Theo H. van der Kwast. Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the Bladder. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.03.030.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Prior to Radical Cystectomy: Induction Versus Neoadjuvant Chemotherapy.
(
- Contribution to journal › Letter
-
Mark
[F-18]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy
(
- Contribution to journal › Article
-
Mark
TURBT Can Cause Seeding of Cancer Cells into the Bloodstream.
(
- Contribution to journal › Article
-
Mark
Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models.
(
- Contribution to journal › Article
-
Mark
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
(
- Contribution to journal › Article
-
Mark
On Molecular Classification of Bladder Cancer: Out of One, Many.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Does Incision Length Matter? Robotic Assisted Extracorporeal Urinary Diversion via Mini-laparotomy Using the Alexis O-ring Retractor.
(
- Contribution to journal › Letter
-
Mark
Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.
(
- Contribution to journal › Article
-
Mark
Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions.
(
- Contribution to journal › Article
-
Mark
Microsurgical Varicocele Repair on Men with Grade III Lesions and Chronic Dull Scrotal Pain: A Pilot Study.
(
- Contribution to journal › Article
- 2014
-
Mark
Is nephrolithiasis an unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective population-based Swedish national cohort study with matched general population comparator subjects.
(
- Contribution to journal › Article
-
Mark
Cellular mechanisms of taxane therapy in castration resistant prostate cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
(
- Contribution to journal › Article
-
Mark
AKT and AMPK Activation after High-Fat and High-Glucose In Vitro Treatment of Prostate Epithelial Cells.
(
- Contribution to journal › Article
-
Mark
(18)F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.
(
- Contribution to journal › Article
-
Mark
Urinary bladder cancer treated with radical cystectomy: Perioperative parameters and early complications prospectively registered in a national population-based database
(
- Contribution to journal › Article
-
Mark
Rediversion after urinary diversion: A single-centre experience.
(
- Contribution to journal › Article
-
Mark
Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.
(
- Contribution to journal › Article
-
Mark
Infiltration of CD3(+) and CD68(+) cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
(
- Contribution to journal › Article
-
Mark
Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals Oncology Jan;25(1): 9-15, 2014).
(
- Contribution to journal › Letter
-
Mark
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
(
- Contribution to journal › Scientific review
-
Mark
EAU Policy on Live Surgery Events.
(
- Contribution to journal › Scientific review
-
Mark
Varicocele repair in non-obstructive azoospermic men: diagnostic value of testicular biopsy - A meta-analysis.
(
- Contribution to journal › Scientific review
-
Mark
The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.
(
- Contribution to journal › Article
-
Mark
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
Intermittent Androgen-deprivation Therapy in Prostate Cancer: A Critical Review Focused on Phase 3 Trials
(
- Contribution to journal › Article
-
Mark
Early Detection of Prostate Cancer: European Association of Urology Recommendation
(
- Contribution to journal › Article
-
Mark
Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.
(
- Contribution to journal › Article
-
Mark
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.
(
- Contribution to journal › Article
-
Mark
Toward a Molecular Pathologic Classification of Urothelial Carcinoma.
(
- Contribution to journal › Article
-
Mark
Expression and localization of serotonin receptors in human breast cancer.
(
- Contribution to journal › Article
-
Mark
New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists
(
- Contribution to journal › Scientific review
-
Mark
Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden
(
- Contribution to journal › Article
- 2012
-
Mark
The androgen receptor and stem cell pathways in prostate and bladder cancers (Review)
(
- Contribution to journal › Scientific review
-
Mark
Very late prostate cancer local recurrence 23 years after radical prostatectomy.
(
- Contribution to journal › Article
-
Mark
Current Vaccination Strategies for Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.
(
- Contribution to journal › Article
-
Mark
The Effect of Baseline Testosterone on the Efficacy of Degarelix and Leuprolide: Further Insights From A 12-Month, Comparative, Phase III Study in Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Regional distribution of neuroendocrine cells in the urogenital duct system of the male rat
(
- Contribution to journal › Article
-
Mark
Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
(
- Contribution to journal › Article
-
Mark
Testosterone in prostate cancer: the Bethesda consensus.
(
- Contribution to journal › Article
-
Mark
DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status.
(
- Contribution to journal › Article
-
Mark
A Molecular Taxonomy for Urothelial Carcinoma.
(
- Contribution to journal › Article
-
Mark
A Plea for Surgical Lymph Node Staging in Advanced Prostate Cancer.
2012) In European Urology(
- Contribution to journal › Letter
-
Mark
Snabba åtgärder vid makrohematuri både angelägna och möjliga.
(
- Contribution to journal › Article
-
Mark
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
(
- Contribution to journal › Article
-
Mark
The Importance of Being Grade 3: WHO 1999 Versus WHO 2004 Pathologic Grading.
(
- Contribution to journal › Article
-
Mark
Microdialysis in Early Detection of Temporary Pancreatic Ischemia in a Porcine Model.
(
- Contribution to journal › Article
-
Mark
Expression of Serotonin Receptors 5-HT1A, 5-HT1B, 5-HT2B and 5-HT4 in Ovary and in Ovarian Tumours.
(
- Contribution to journal › Article
-
Mark
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index.
(
- Contribution to journal › Article
-
Mark
Laparoscopic extended pelvic lymphadenectomy for staging can be performed with limited morbidity and short hospital stay in patients with prostate cancer.
(
- Contribution to journal › Article
-
Mark
Targeting the human kallikrein-2 (hK2) expression in prostate cancer using 111In-labelled monoclonal antibody 11B6
2012) p.1102-1102(
- Contribution to conference › Abstract
- 2011
-
Mark
C-JUN INTERVENES WITH DOCETAXEL THERAPY IN CASTRATION-RESISTANT PROSTATE CANCER: AR STILL MATTERS
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.294-294(
- Contribution to journal › Published meeting abstract
-
Mark
Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
(
- Contribution to journal › Article
-
Mark
Clinical Trial Update and Novel Therapeutic Approaches for Metastatic Prostate Cancer.
(
- Contribution to journal › Article
- 2010
-
Mark
HIF1 alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation
(
- Contribution to journal › Article
-
Mark
Identification of urothelial stem cells for tissue engineering
(
- Contribution to journal › Published meeting abstract
-
Mark
Label retaining cells and stem cell marker expression in the developing and adult mouse prostate
(
- Contribution to journal › Published meeting abstract
-
Mark
European Association of Urology. Position statement on screening for prostate cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Burden of metastatic bone disease from genitourinary malignancies
(
- Contribution to journal › Scientific review
-
Mark
Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy
(
- Contribution to journal › Article
-
Mark
PCA3 as a diagnostic marker for prostate cancer: A validation study on a Swedish patient population.
(
- Contribution to journal › Article
-
Mark
Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model.
(
- Contribution to journal › Article
-
Mark
Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature.
(
- Contribution to journal › Article
-
Mark
Reply to Tomasz Drewa's Letter to the Editor re: Per-Anders Abrahamsson. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol 2010;57:49-59.
(
- Contribution to journal › Letter
- 2009
-
Mark
Prostate Cancer: To Treat or Not to Treat?
(
- Contribution to journal › Article
-
Mark
Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates
(
- Contribution to journal › Scientific review
-
Mark
Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study
(
- Contribution to journal › Article
-
Mark
SOMATOSTATIN IS EXPRESSED IN THE HUMAN PROSTATE STEM CELL NICHE AND INHIBITS EXPANSION OF LUMINAL PRECURSOR CELLS
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.248-248(
- Contribution to journal › Published meeting abstract
-
Mark
CYCLIN A1 MEDIATES DRUG-RESISTANT METASTATIC SPREAD OF PCA CELLS IN XENOGRAFTS IN VIVO
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.343-343(
- Contribution to journal › Published meeting abstract
-
Mark
European Association of Urology Position Statement on Screening for Prostate Cancer.
(
- Contribution to journal › Letter
-
Mark
COMPARING TESTOSTERONE AND PSA FOR DIFFERENT BASELINE TESTOSTERONE CONCENTRATIONS DURING INITIATION OF DEGARELIX AND LEUPROLIDE TREATMENT
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.130-130(
- Contribution to journal › Published meeting abstract
-
Mark
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Brain irradiation: effects on normal brain parenchyma and radiation injury.
(
- Contribution to journal › Article
-
Mark
The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
(
- Contribution to journal › Article
-
Mark
The developing role of hormonal therapy in the treatment of prostate cancer.
(
- Contribution to journal › Article
-
Mark
The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.
(
- Contribution to journal › Article
-
Mark
EAU-a work in progress-what comes next?
(
- Contribution to journal › Letter
-
Mark
Treatment of prostate cancer with hormonal therapy in Europe
(
- Contribution to journal › Article
- 2008
-
Mark
Intermittent DHT administration enhances effect of docetaxel in a xenograft model by modulation of ER beta, AR and NEK2
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.278-278(
- Contribution to journal › Published meeting abstract
-
Mark
Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
(
- Contribution to journal › Article
-
Mark
PSA-based screening for prostate cancer: How does it compare with other cancer screening tests?
(
- Contribution to journal › Scientific review
-
Mark
Malignant lesions in the ventral prostate of alloxan-induced diabetic rats
(
- Contribution to journal › Article
-
Mark
The Identification of a Novel Stromal Stem/Progenitor Cell Phenotype in the Human Adult Prostate
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.93-93(
- Contribution to journal › Published meeting abstract
-
Mark
Hormonal regulation of beta(2)-adrenergic receptor level in prostate cancer
(
- Contribution to journal › Article
-
Mark
Characterization Of Non-Small Cell Lung Cancer Using Tiling Resolution Bacterial Artificial Chromosome Microarrays
(
- Contribution to journal › Published meeting abstract
-
Mark
Association between tobacco exposure and reproductive parameters in adolescent males.
(
- Contribution to journal › Article
-
Mark
Nordic observational study evaluating safety and analgesic consumption in patients with advanced cancer under zoledronic acid (ZOMETA (R)) treatment: NOSAZ-interim analysis
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.232-232(
- Contribution to journal › Published meeting abstract
-
Mark
Reduced risk of prostate cancer in infertile men compared to men with proven fertility: A nested case-control study
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.197-197(
- Contribution to journal › Published meeting abstract
-
Mark
Nordic Observational Study Evaluating Safety And Analgesic Use In Patients With Advanced Cancer Under Zoledronic Acid Treatment Interim Analysis
(
- Contribution to journal › Published meeting abstract
-
Mark
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
(
- Contribution to journal › Article
-
Mark
Do we need PSA and early detection of prostate cancer?
(
- Contribution to journal › Article
-
Mark
Regulatory Proteins in Progenitors and Differentiated Cells of the Human Prostate
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The characterization of epithelial and stromal subsets of candidate stem/progenitor cells in the human adult prostate.
(
- Contribution to journal › Article
-
Mark
Prostate cancer and active surveillance.
(
- Contribution to journal › Article
-
Mark
Delta-Like 1 (Dlk-1), a Novel Marker of Prostate Basal and Candidate Epithelial Stem Cells, Is Downregulated by Notch Signalling in Intermediate/Transit Amplifying Cells of the Human Prostate.
(
- Contribution to journal › Article
-
Mark
Management of advanced prostate cancer: can we improve on androgen deprivation therapy?
(
- Contribution to journal › Article
- 2007
-
Mark
Active surveillance vs radical prostatectomy.
(
- Contribution to journal › Article
-
Mark
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer
(
- Contribution to journal › Article
-
Mark
Functional in vitro characterisation of the androgen receptor GGN polymorphism.
(
- Contribution to journal › Article
-
Mark
Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
(
- Contribution to journal › Article
-
Mark
Adjuvant radiotherapy after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
The continuing role of PSA in the detection and management of prostate cancer
(
- Contribution to journal › Article
- 2006
-
Mark
Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer
(
- Contribution to journal › Article
-
Mark
Hormone therapy: Improving therapy decisions and monitoring
(
- Contribution to journal › Article
-
Mark
The role of finasteride in the management of BPH and in the prevention of prostate cancer - Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Interview with Professor Per-Anders Abrahamson: Angiogenesis and renal cell carcinoma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Advances in Biomarkers for Prostate Diseases
2006) p.85-85(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The Prostate Cancer Prevention Trial and its implications for clinical practice: A European consensus
(
- Contribution to journal › Article
-
Mark
The role of PSA kinetics in the management of prostate cancer
(
- Contribution to journal › Article
- 2005
-
Mark
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.
(
- Contribution to journal › Article
-
Mark
Expression of Serotonin Receptors 2B and 4 in Human Prostate Cancer Tissue and Effects of Their Antagonists on Prostate Cancer Cell Lines.
(
- Contribution to journal › Article
-
Mark
The 5alpha-Reductase Type II A49T and V89L High-Activity Allelic Variants are More Common in Men with Prostate Cancer Compared with the General Population.
(
- Contribution to journal › Article
-
Mark
Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
(
- Contribution to journal › Scientific review
-
Mark
Epididymal and accessory sex gland function and semen quality
2005)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Role of somatostatin receptors in prostate carcinoma
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer.
(
- Contribution to journal › Scientific review
-
Mark
Prognostic value of serum markers for prostate cancer
(
- Contribution to journal › Article
- 2004
-
Mark
Long-term testosterone stimulation induces hyperplasia in the guinea-pig prostate.
(
- Contribution to journal › Article
-
Mark
Pathophysiology of bone metastases in prostate cancer
(
- Contribution to journal › Article
-
Mark
Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data.
(
- Contribution to journal › Article
-
Mark
Behandlingsmodell med Somatostatinanaloger vid Hor
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas.
(
- Contribution to journal › Article
-
Mark
Cystatin C is highly expressed in the human male reproductive system.
(
- Contribution to journal › Article
-
Mark
Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
(
- Contribution to journal › Article
- 2003
-
Mark
No association between mutations in the human androgen receptor GGN repeat and inter-sex conditions
(
- Contribution to journal › Article
-
Mark
Prostate specific antigen and human glandular kallikrein 2 in early detection of prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Neuroendocrine differentiation in prostatic carcinoma.
(
- Contribution to journal › Article
-
Mark
Revolutions in the management of hormone-refractory prostate cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues
(
- Contribution to journal › Article
- 2002
-
Mark
Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
(
- Contribution to journal › Article
-
Mark
Neuroendocrine Mediators in Prostate Cancer Progression
2002) p.279-279(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer.
(
- Contribution to journal › Article
-
Mark
Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial
(
- Contribution to journal › Article
- 2001
-
Mark
Neuroendocrine cells and nerves in the prostate of the guinea pig: effects of peripheral denervation and castration
(
- Contribution to journal › Article
-
Mark
Neuroendocrine pathogenesis in adenocarcinoma of the prostate
(
- Contribution to journal › Article
- 2000
-
Mark
Calcitonin and calcitonin gene-related peptide in the human prostate gland
(
- Contribution to journal › Article
-
Mark
Expression and characterization of trypsinogen produced in the human male genital tract
(
- Contribution to journal › Article
- 1999
-
Mark
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL
(
- Contribution to journal › Article
-
Mark
Localization of protein gene product 9.5 immunoreactivity in derivatives of the human Wolffian duct and in prostate cancer
(
- Contribution to journal › Article
- 1998
-
Mark
Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum
(
- Contribution to journal › Article
-
Mark
Forskningsframsteg om hereditär prostatacancer. Riskfamiljer bör kartläggas och erbjudas screening
(
- Contribution to journal › Article
- 1996
-
Mark
Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer
(
- Contribution to journal › Article
-
Mark
Cytogenetic studies of normal kidney tissue and renal cell carcinoma
1996)(
- Thesis › Doctoral thesis (compilation)
- 1995
-
Mark
Free, Complexed and Total Serum Prostate Specific Antigen : The Establishment of Appropriate Reference Ranges for their Concentrations and Ratios
(
- Contribution to journal › Article
- 1994
-
Mark
Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia
(
- Contribution to journal › Article
- 1992
-
Mark
Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system
(
- Contribution to journal › Article
- 1990
-
Mark
Species‐ and organ‐specificity of secretory proteins derived from human prostate and seminal vesicles
(
- Contribution to journal › Article
-
Mark
Three predominant prostatic proteins : Drei vorherrschende Prostataproteine
(
- Contribution to journal › Article
- 1989
-
Mark
Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa
(
- Contribution to journal › Article